Up-regulation of human leukocyte antigen G expression in primary cutaneous malignant melanoma associated with host-vs-tumor immune response

Abstract

Human leukocyte antigen G (HLA-G) is one of the molecules implicated in immunotolerance. To investigate the role of HLA-G in primary cutaneous malignant melanoma (CMM), a series of 47 skin melanocytic lesions were immunohistochemically evaluated. The correlation between HLA-G expression and CMM clinicohistopathological data and Bcl-2 expression was also analyzed. HLA-G expression was detected in a variety of cell types. No significant difference in HLA-G expression was observed between malignant and non-malignant melanocytic lesions. HLA-G expression was significantly correlated with the inflammatory infiltration and Bcl-2 expression, whereas no significant correlation with ulceration, tumor thickness, clinical stage, histopathological subtypes were observed. HLA-G expression may be the result of host immune reaction in tumor microenvironment rather than a malignant feature of CMM.

Keywords

cutaneous malignant melanoma / human leukocyte antigen G

References

[1] Rouas-FreissN., MoreauP., FerroneS., et al.. HLA-G Proteins in Cancer: Do They Provide Tumor Cells with an Escape Mechanism?. Cancer Res, 2005, 65(22): 10139-10144

[2] PaulP., Rouas-FreissN., Khalil-DaherI., et al.. HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance. Immunol, 1998, 59(8): 4510-4515

[3] IbrahimelC., AractingiS., AlloryY., et al.. Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-Al genotype. Int J Cancer, 2004, 108(2): 243-2450

[4] van KempenL. C., RuiterD. J., van MuijenG. N., et al.. The tumor microenvironment: a critical determinant of neo-plastic evolution. Eur J Cell Biol, 2003, 82(11): 539-548

[5] LeMaoultJ., Le DiscordeM., Rouas-FreissN., et al.. Biol-ogy and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens, 2003, 62(4): 273-284

[6] ReedJ. A., AlbinoA. P.. Update of diagnostic and prognostic markers in cutaneous malignant melanoma. Clin Lab Med, 2000, 20(4): 817-838